Balanced news tone
News Sentiment
AVCT sentiment intelligence
Avacta Group Plc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
49
Balanced news tone
25 relevant articles
News tone and price action are not far from neutral.
91/100 classification confidence.
directly relevant articles
high-authority source matches
+2.8% over one week, -7.6% over four weeks, trend active, and near fair-value range.
Avacta Extends Cash Runway as Clinical Pipeline Advances
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
91/100 classification
One-week reaction
2.8%
Price confirming higher
Trend fit
Trend active
-7.6% over four weeks
Fair value
5.6%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
0
Neutral
24
Negative
1
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Share Talk
Direct company coverage
Avacta Extends Cash Runway as Clinical Pipeline Advances
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 22 Jun 2026 06:29
- Source
- Share Talk
Market source
Direct company coverage
Avacta Secures £9m Fundraise to Reduce Debt Burden and Advance Cancer Drug Development (AVCT)
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 05 Jun 2026 07:00
- Source
- Market source
Share Talk
Direct company coverage
£9m fundraising gives Avacta extra firepower for cancer pipeline
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- Share Talk
Investing.com UK
Direct company coverage
Avacta applies for block listing of 5.5 million shares on AIM
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Investing.com UK
Share Talk
Direct company coverage
Avacta Therapeutics (AIM: AVCT) Pre|CISION® payload release vs approved ADCs
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 May 2026 07:00
- Source
- Share Talk
Share Talk
Direct company coverage
Avacta Therapeutics (AIM: AVCT) Avacta data AACR underline AVA6103 profile
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Apr 2026 07:00
- Source
- Share Talk
Share Talk
Direct company coverage
Avacta Therapeutics (AIM: AVCT) Christina Coughlin – In Vivo 2026 Rising Leader
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Apr 2026 07:00
- Source
- Share Talk
Share Talk
Direct company coverage
Avacta Therapeutics (AIM: AVCT) Q1 2026 Business Update
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Apr 2026 07:00
- Source
- Share Talk
Share Talk
Direct company coverage
Avacta Therapeutics (AIM: AVCT) Announces 2026 Science Day Event
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Apr 2026 07:00
- Source
- Share Talk
Share Talk
Direct company coverage
Avacta Therapeutics (AIM: AVCT) Result of Oversubscribed Fundraise
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Mar 2026 07:00
- Source
- Share Talk
Share Talk
Direct company coverage
Avacta Therapeutics (AIM: AVCT) Phase 1 study opening for AVA6103
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Mar 2026 07:00
- Source
- Share Talk
Share Talk
Direct company coverage
Avacta Therapeutics (AIM: AVCT) PreCISION payload delivery advantage over ADC
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Feb 2026 08:00
- Source
- Share Talk
Market source
Direct company coverage
With 75% institutional ownership, Avacta Group Plc (LON:AVCT) is a favorite amongst the big guns
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Feb 2026 08:00
- Source
- Market source
Share Talk
Direct company coverage
Avacta Therapeutics (AIM: AVCT) Appoints Francis Wilson as Chief Scientific Officer
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Feb 2026 08:00
- Source
- Share Talk
Share Talk
Direct company coverage
Avacta Therapeutics (AIM: AVCT) Faridoxorubicin Program Clinical Updates
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Feb 2026 08:00
- Source
- Share Talk
Share Talk
Direct company coverage
Avacta Therapeutics (AIM: AVCT) FDA Clearance of IND Application for AVA6103
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Jan 2026 08:00
- Source
- Share Talk
Kalkine Media
Direct company coverage
Avacta Group Plc FTSE AIM All Share Focused Update on Biotechnology Operations
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jan 2026 08:00
- Source
- Kalkine Media
simplywall.st
Direct company coverage
Avacta Group Plc's (LON:AVCT) market cap decline of UK£37m may not have as much of an impact on institutional owners after a year of 7.9% returns
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 14 Jan 2026 08:00
- Source
- simplywall.st
Share Talk
Direct company coverage
Avacta Therapeutics (AIM: AVCT) reports new AVA6103 pharmacology data
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Dec 2025 08:00
- Source
- Share Talk
Share Talk
Direct company coverage
Avacta Therapeutics (AIM: AVCT) Preliminary Data in Faridoxorubicin Phase 1b Trial
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Dec 2025 08:00
- Source
- Share Talk
AskTraders
Direct company coverage
Avacta Shares – AVCT Price and Forecast
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 23 Jul 2024 19:17
- Source
- AskTraders
StockInvest.us
Direct company coverage
AVCT.L - Avacta Group plc Company Profile
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jul 2019 08:35
- Source
- StockInvest.us
Hargreaves Lansdown
Direct company coverage
Avacta Group plc Ordinary 10p share price | AVCT
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jul 2018 12:06
- Source
- Hargreaves Lansdown
TradingView
Direct company coverage
AVCT Stock Price and Chart — LSE:AVCT
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Aug 2017 08:00
- Source
- TradingView
MarketBeat
Direct company coverage
Avacta Group (AVCT) Share Price, Stock Value, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Aug 2016 06:43
- Source
- MarketBeat